| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.STR.0000217384.03237.9C |
| P698 | PubMed publication ID | 16574924 |
| P2093 | author name string | Massimo Musicco | |
| Immacolata Piccolo | |||
| Paola Soliveri | |||
| Floriano Girotti | |||
| Gabriele Ronchetti | |||
| Giulio Scigliano | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 1184-1188 | |
| P577 | publication date | 2006-03-30 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study | |
| P478 | volume | 37 |
| Q90348452 | "New methods of assessing autonomic disorders in Parkinson disease patients: skin-galvanic reaction" |
| Q92220413 | Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review |
| Q36852489 | Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis |
| Q38063423 | Arterial hypertension, a tricky side of Parkinson's disease: physiopathology and therapeutic features |
| Q37409148 | Assessment of platelet indices in patients with neurodegenerative diseases: mean platelet volume was increased in patients with Parkinson's disease |
| Q64073771 | Association between carotid plaque and Parkinson's disease |
| Q37124518 | Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease |
| Q64782430 | Brain cholesterol metabolism and Parkinson's disease |
| Q41324336 | Cardiovascular Diseases in ~30,000 Patients in the Swedish Dementia Registry |
| Q64819975 | Cardiovascular risk factors and the risk of Parkinson's disease |
| Q42145966 | Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk |
| Q33687062 | Comorbidity burden of patients with Parkinson's disease and Parkinsonism between 2003 and 2012: A multicentre, nationwide, retrospective study in China. |
| Q28074143 | Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease |
| Q35632270 | Correlation between biochemical indicators of blood lipid with cerebral vascular diseases |
| Q64860751 | Demographic features and clinical characteristics of patients with Parkinson's disease in Isfahan, Iran |
| Q34718429 | Diabetes and risk of Parkinson's disease |
| Q26849796 | Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis |
| Q28538916 | Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies |
| Q35043736 | Diabetes and the risk of developing Parkinson's disease in Denmark. |
| Q38665903 | Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry |
| Q36842047 | Diabetes in patients with idiopathic Parkinson's disease |
| Q37731946 | Diet and age interactions with regards to cholesterol regulation and brain pathogenesis |
| Q37362433 | Dietary fats, cholesterol and iron as risk factors for Parkinson's disease |
| Q35492403 | Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells |
| Q37053839 | Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders |
| Q64054875 | Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson's Disease |
| Q51623318 | Effect of heart rate on the risk of developing metabolic syndrome. |
| Q97518174 | Effects of Higher Serum Lipid Levels on the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis |
| Q39552785 | Frontal white matter injuries predestine gait difficulties in Parkinson's disease |
| Q61449892 | Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson's Disease Induced by 6-OHDA |
| Q34614842 | HDL and cognition in neurodegenerative disorders. |
| Q36983489 | Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson's Disease |
| Q37900480 | How might physical activity benefit patients with Parkinson disease? |
| Q59153352 | Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease |
| Q37580065 | Lipid dysfunction and pathogenesis of multiple system atrophy |
| Q45306964 | Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives |
| Q33693961 | Mechanisms of body weight fluctuations in Parkinson's disease |
| Q57210882 | Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study |
| Q27023711 | Metabolic syndrome: an important risk factor for Parkinson's disease |
| Q37267160 | Non-genetic factors associated with the risk of Parkinson's disease in Iranian patients |
| Q64240263 | Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways |
| Q61451961 | Parkinson's Disease in Intensive Care Unit: An Observational Study of Frequencies, Causes, and Outcomes |
| Q34983826 | Parkinson's disease is related to an increased risk of ischemic stroke-a population-based propensity score-matched follow-up study |
| Q58764907 | Prevalent cerebrovascular and cardiovascular disease in people with Parkinson's disease: a meta-analysis |
| Q90003926 | Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages |
| Q36906241 | Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease |
| Q35005934 | Reduced serum levels of triglyceride, very low density lipoprotein cholesterol and apolipoprotein B in Parkinson's disease patients |
| Q37299447 | Reduced striatal tyrosine hydroxylase in incidental Lewy body disease |
| Q55251043 | Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease. |
| Q33348468 | Reply: Plasma cholesterol and Parkinson's disease: Is the puzzle only apparent? |
| Q36891855 | Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies |
| Q35101405 | Serum adiponectin levels in advanced-stage Parkinson's disease patients |
| Q34243731 | Serum cholesterol and nigrostriatal R2* values in Parkinson's disease |
| Q33996828 | Serum cholesterol and the progression of Parkinson's disease: results from DATATOP. |
| Q44466026 | Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population |
| Q38859501 | Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database |
| Q35328089 | Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study |
| Q61804251 | The Role of Lipids in Parkinson's Disease |
| Q38376727 | The influence of vascular risk factors on cognitive function in early Parkinson's disease |
| Q35552497 | The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease |
| Q51313784 | The serum lipid profile of Parkinson's disease patients: a study from China. |
| Q38539827 | The serum lipid profiles of amyotrophic lateral sclerosis patients: A study from south-west China and a meta-analysis |
| Q34212035 | Total cholesterol and the risk of Parkinson's disease: a review for some new findings |
| Q37778567 | Transcranial Sonography in the Discrimination of Parkinson’s Disease Versus Vascular Parkinsonism |
| Q99238282 | Tremor in Vascular Cognitive Impairment Raises the Possibility of Mixed Pathology With Lewy Body Disease |
Search more.